ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ КОМБИНИРОВАННОЙ ТЕРАПИИ ЛИЗИНОПРИЛОМ И СИМВАСТАТИНОМ – РЕЗУЛЬТАТЫ ИССЛЕДОВАНИЯ «ЭЛАСТИКА»

1. Национальные рекомендации по диагностике и лечению артериальной гипертензии (третий пересмотр)//Кардиоваскулярная терапия и профилактика 2008;7(6). Приложение 2.

2. Национальные рекомендации по диагностике и коррекции нарушений липидного обмена с целью профилактики и лечения атеросклероза (третий пересмотр)//Кардиоваскулярная терапия и профилактика 2007;6(6). Приложение 3.

3. Vascular Endothelium. Physiology, pathology, and therapeutic opportunities/ Editors Born GV and Shwartz CJ. – Stuttgart: Schattauer, 1997.

4. Angiotensin Converting Ensyme Inhibitors: the advance continues/ 3th edit. Lionel H.Opie. Author’s publishing house New York, University of Сape Town Press, 1999.

5. О.П.Шевченко, А.О.Шевченко. Статины. Ингибиторы ГМГ- КоА-редуктазы// Реафарм, Москва, 2003.

6. Аронов Д.М. Плеотропные эффекты статинов// Кардиология 2008; 8: 60-68.

7. Scribner A., Loscalzo J., Napoli C. The effect of angiotensinconverting enzyme inhibition on endothelial function and oxidant stress// Eur. J. Pharmacol. 2003;482:95—9.

8. Sever P. et al. Potential synergy between lipid-lowering and bloodpressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial// Eur. Heart J. (2006) 27, 2982-2988.

9. Sever P., Poulter N. Blood pressure reduction is not the only determinant of outcome// Circulation 2006;113: 2754-2774.

10. Athyros VG et al. Effect of statins and ACE inhibitors alone in combination on clinical outcome in patients with coronary heart disease// J. Hum. Hypertens. 2004; 11:781-788.

11. Borgi C. Interaction between hypercholesterolemia and hypertension: implication for therapy// Curr Opin Nephrol Hypertens 2002; 11:489-496.

12. Heart Protection Study Collaboration Group. MRC/BHF Heart Protection Studyof cholesterol lowering with simvastatin in 20536 hogh-risk individuals: a randomized placebo-controlled trial// Lancet 2002;360:7-22.

13. Zanchetti A. et al. Different effects of antihypertensive regimens based on fosinopril of hydrochorothiazide with of without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS – a randomized double-blind trial//Stroke 2004;35:2807-2812.

14. Ridker P. et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein// N Engl J Med 2008; 359: 2195-2207.

15. Bots M, Remme W, Luscher T. et al. ACE inhibition and endothelial function: The PERFECT study, sub study of the EUROPA trial: Main findings// J Hypertens. 2005;23(suppl 2):S21. Abstract 3B.4.

16. Bots ML et al. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response// Eur. Heart J. (2005) 26,363- 368.